MONDELLO, Stefania
 Distribuzione geografica
Continente #
EU - Europa 6.257
NA - Nord America 4.265
AS - Asia 2.001
SA - Sud America 1.334
AF - Africa 74
Continente sconosciuto - Info sul continente non disponibili 8
OC - Oceania 8
Totale 13.947
Nazione #
US - Stati Uniti d'America 4.194
RU - Federazione Russa 3.029
BR - Brasile 1.224
IE - Irlanda 1.152
SG - Singapore 854
CN - Cina 740
SE - Svezia 692
IT - Italia 409
FI - Finlandia 233
DE - Germania 225
PL - Polonia 127
GB - Regno Unito 122
UA - Ucraina 99
HK - Hong Kong 74
IN - India 45
TR - Turchia 37
AR - Argentina 35
FR - Francia 35
VN - Vietnam 32
IQ - Iraq 31
AT - Austria 29
MX - Messico 27
UZ - Uzbekistan 26
BE - Belgio 24
BD - Bangladesh 23
EC - Ecuador 23
NL - Olanda 23
MA - Marocco 22
CA - Canada 18
PK - Pakistan 16
ZA - Sudafrica 16
CZ - Repubblica Ceca 13
ID - Indonesia 13
IR - Iran 13
CO - Colombia 12
EG - Egitto 11
VE - Venezuela 10
JO - Giordania 9
KE - Kenya 9
PE - Perù 9
UY - Uruguay 9
JP - Giappone 8
KR - Corea 8
NP - Nepal 8
TN - Tunisia 8
AL - Albania 7
BH - Bahrain 7
AE - Emirati Arabi Uniti 6
AU - Australia 6
DK - Danimarca 6
JM - Giamaica 6
KZ - Kazakistan 6
OM - Oman 6
AZ - Azerbaigian 5
PA - Panama 5
BO - Bolivia 4
CL - Cile 4
CR - Costa Rica 4
DO - Repubblica Dominicana 4
HU - Ungheria 4
IL - Israele 4
KG - Kirghizistan 4
PS - Palestinian Territory 4
PY - Paraguay 4
RO - Romania 4
XK - ???statistics.table.value.countryCode.XK??? 4
AM - Armenia 3
CH - Svizzera 3
DZ - Algeria 3
ES - Italia 3
EU - Europa 3
GR - Grecia 3
HN - Honduras 3
LB - Libano 3
LK - Sri Lanka 3
LT - Lituania 3
NI - Nicaragua 3
SK - Slovacchia (Repubblica Slovacca) 3
NZ - Nuova Zelanda 2
PH - Filippine 2
RS - Serbia 2
SA - Arabia Saudita 2
SN - Senegal 2
TW - Taiwan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
CI - Costa d'Avorio 1
CY - Cipro 1
GA - Gabon 1
GE - Georgia 1
HR - Croazia 1
IS - Islanda 1
KW - Kuwait 1
LV - Lettonia 1
MN - Mongolia 1
MY - Malesia 1
NO - Norvegia 1
PT - Portogallo 1
Totale 13.944
Città #
Moscow 2.978
Dublin 1.150
Chandler 777
Singapore 450
Nyköping 379
Jacksonville 324
Beijing 254
Princeton 239
Medford 216
Messina 187
Dearborn 184
Des Moines 180
Cambridge 175
Ashburn 174
Warsaw 127
Munich 113
Boardman 93
Ann Arbor 89
Wilmington 88
New York 86
The Dalles 76
São Paulo 75
Hong Kong 73
Houston 64
Lancaster 57
San Mateo 55
Shenyang 55
Helsinki 54
Jinan 51
Nanjing 36
Woodbridge 36
Seattle 35
Belo Horizonte 30
Tianjin 30
Los Angeles 29
Dong Ket 28
Haikou 27
Rio de Janeiro 27
Zhengzhou 26
Nuremberg 24
Taizhou 24
Brasília 23
Tashkent 23
Brussels 22
Hebei 22
Pune 22
Salvador 21
Rome 20
Vienna 19
Ningbo 17
Campinas 16
Curitiba 16
Hangzhou 16
Baghdad 15
Nanchang 15
Catania 14
Falls Church 14
Hyderabad 14
Norwalk 14
Jiaxing 13
Brno 11
Jakarta 11
Porto Alegre 11
Duque de Caxias 10
Fuzhou 10
Goiânia 10
Guarulhos 10
Istanbul 10
Sorocaba 10
Washington 10
Changsha 9
Council Bluffs 9
Guayaquil 9
Lanzhou 9
Lappeenranta 9
Milan 9
Santo André 9
Uberlândia 9
Amman 8
Hefei 8
Montevideo 8
Pelotas 8
Ribeirão Preto 8
Rio Grande 8
São Bernardo do Campo 8
São Gonçalo 8
Volta Redonda 8
Belém 7
Betim 7
Bremen 7
Contagem 7
Düsseldorf 7
Frankfurt am Main 7
London 7
Manama 7
Ottawa 7
Paris 7
Ribeirão das Neves 7
São José dos Campos 7
Tappahannock 7
Totale 9.849
Nome #
Increased levels of serum MAP-2 at 6-months correlate with improved outcome in survivors of severe traumatic brain injury 3.003
Burden of non-communicable disease studies in Europe: a systematic review of data sources and methodological choices 156
Autoantibodies in traumatic brain injury and central nervous system trauma. 120
Emerging markers of cachexia predict survival in cancer patients. 109
Health-related quality of life and functional changes in DMD: A 12-month longitudinal cohort study 108
Perceived Stress in a Gender Perspective: A Survey in a Population of Unemployed Subjects of Southern Italy 107
Accuracy of Cystosonography without Voiding Phase in the Diagnosis of Vesicoureteral Reflux in Children: A Variant of the Original Technique 106
Intracranial arterial abnormalities in patients with late onset Pompe disease (LOPD) 105
Assessment of Serum UCH-L1 and GFAP in Acute Stroke Patients 103
Behavior of vascular endothelial growth factor and erythropoietin throughout the menstrual cycle in healthy women. 102
Vacuolated PAS-positive lymphocytes on blood smear: An easy screening tool and a possible biomarker for monitoring therapeutic responses in Late Onset Pompe Disease (LOPD) 99
Degradation of βII-Spectrin Protein by Calpain-2 and Caspase-3 Under Neurotoxic and Traumatic Brain Injury Conditions. 92
A Direct Cortico-Nigral Pathway as Revealed by Constrained Spherical Deconvolution Tractography in Humans 92
Cancer cachexia syndrome: pathogenesis, diagnosis, and new therapeutic options 91
Data comparison between pharmacological induction of labour and spontaneous delivery. A single centre experience 89
alphaII-Spectrin Breakdown Products (SBDPs): Diagnosis and Outcome in Severe Traumatic Brain Injury Patients 87
Serum Concentrations of Ubiquitin C-Terminal Hydrolase-L1 and Glial Fibrillary Acidic Protein after Pediatric Traumatic Brain Injury 87
Nodal Ratio as a Prognostic Factor in Patients with Four or More Positive Axillary Nodes Treated with Breast-conserving Therapy and Regional Nodal Irradiation 87
Night shift work in resident physicians: does it affect mood states and cognitive levels? 85
Glutamine-supplemented total parenteral nutrition improves immunological status in anorectic patients 83
H1299R Variant in Factor V and Recurrent Pregnancy Loss: A Systematic Review and Meta-Analysis Protocol 82
Clinical and molecular aspects of 30 patients with late-onset Pompe disease (LOPD): unusual features and response to treatment 82
p-CREB expression in human gliomas: potential use in the differential diagnosis between astrocytoma and oligodendroglioma. 80
LOPED study: Looking for an early diagnosis in a late-onset Pompe disease high-risk population 80
EFFETTI DEL LAVORO A TURNI E NOTTURNO SU LIVELLI COGNITIVI E STATI DELL’UMORE NEI MEDICI IN FORMAZIONE SPECIALISTICA: DATI PRELIMINARI 79
Quantitative pupillometry and neuron-specific enolase independently predict return of spontaneous circulation following cardiogenic out-of-hospital cardiac arrest: a prospective pilot study 78
Fast Magnetic Resonance Enterography Protocol for the Evaluation of Patients with Crohn's Disease: A Pilot Study 77
Ubiquitin C-Terminal Hydrolase (UCH-L1): Correlations Exist Between Biofluid Kinetics and Clinical Outcome In Severe Traumatic Brain Injury Patients 75
Renal complications in oncohematologic patients. 75
Thyroid hormone autoantibodies: Are they a better marker to detect early thyroid damage in patients with hematologic cancers receiving tyrosine kinase inhibitor or immunoregulatory drug treatments? 74
Approach to Modeling, Therapy Evaluation, Drug Selection, and Biomarker Assessments for a Multicenter Pre-Clinical Drug Screening Consortium for Acute Therapies in Severe Traumatic Brain Injury: Operation Brain Trauma Therapy 73
Bioinformatics approach to understanding interacting pathways in neuropsychiatric disorders. 71
Glutamine treatment attenuates the development of ischaemia/reperfusion injury of the gut. 71
Acute diagnostic biomarkers for spinal cord injury: review of the literature and preliminary research report 71
A simulated fast magnetic resonance enterography protocol in patients with Crohn's disease: a retrospective, randomized, double-blind study. 71
Anesthetic techniques and cancer recurrence after surgery. 71
Occult hepatitis B virus in liver tissue of individuals without hepatic disease. 70
Erythropoietin Does Not Alter Serum Profiles of Neuronal and Axonal Biomarkers After Traumatic Brain Injury: Findings From the Australian EPO-TBI Clinical Trial 70
Angiotensin receptor antagonists: a potential neuroprotective strategy after brain trauma*. 69
Assessing the influence of age and gender on the phenotype of myotonic dystrophy type 2 69
Method to Detect, Monitor and Promote Neural Regeneration and Improvement of Cognitive Function in a Subject Suffering from Neural Injury 68
Predictors of adaptation to non-invasive ventilation in neuromuscular disorders. 68
Nicotinamide Treatment in Traumatic Brain Injury: Operation Brain Trauma Therapy 68
Glutamine treatment attenuates the development of organ injury induced by zymosan administration in mice 66
Complications of trauma patients admitted to the ICU in level i academic trauma centers in the United States 66
Acute Temporal Profiles of Serum Levels of UCH-L1 and GFAP and Relationships to Neuronal and Astroglial Pathology following Traumatic Brain Injury in Rats 66
High-Dose Robotic Stereotactic Body Radiotherapy in the Treatment of Patients With Prostate Cancer: Preliminary Results in 26 Patients 66
Lymphocytic vasculitis associated with icodextrin. 65
Ubiquitin Carboxy-Terminal Hydrolase L1 (UCH-L1) is increased in cerebrospinal fluid and plasma of patients after epileptic seizure 65
Prognostic factors in patients treated with stereotactic image-guided robotic radiosurgery for brain metastases: a single-center retrospective analysis of 223 patients 65
Psoriasis and cardiovascular risk: correlation between psoriasis and cardiovascular functional indices 64
Thalidomide suppresses sclerosing encapsulating peritonitis in a rat experimental model 63
CSF and Plasma Amyloid-b Temporal Profiles and Relationships with Neurological Status and Mortality after Severe Traumatic Brain Injury: Results of a Pilot Study 63
Assessing Neuro-Systemic & Behavioral Components in the Pathophysiology of Blast-Related Brain Injury. 63
Hypophosphatemia as unusual cause of ARDS in Cushing's syndrome secondary to ectopic CRH production. A case report 62
Glutamine contributes to ameliorate inflammation after renal ischemia/reperfusion injury in rats 62
The Challenge of Mild Traumatic Brain Injury: Role of Biochemical Markers in Diagnosis of Brain Damage. 62
ASSESSING A NECROSIS AND APOPTOSIS INDEX USING CSF alpha II-SPECTRIN BREAKDOWN PRODUCT LEVELS IN SEVERE TBI 62
Necrotizing fasciitis as a rare complication of osteonecrosis of the jaw in a patient with multiple myeloma treated with lenalidomide: case report and review of the literature. 62
Biokinetic Analysis of Ubiquitin C-Terminal Hydrolase-L1 (UCH-L1) in Severe Traumatic Brain Injury Patient Biofluids 62
New astroglial injury-defined biomarkers for neurotrauma assessment 62
Blood-based Diagnostics of Traumatic Brain Injury 61
The hypothalamic-neurohypophyseal system: current and future treatment of vasopressin and oxytocyn related disorders. 61
Global, regional, and national burden of traumatic brain injury and spinal cord injury, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016 60
Elevated Levels of Serum Glial Fibrillary Acidic Protein Breakdown Products in Mild and Moderate Traumatic Brain Injury Are Associated With Intracranial Lesions and Neurosurgical Intervention. 60
Alpha-synuclein Levels in the Cerebrospinal Fluid of Patients with Parkinson’s Disease and Atypical Parkinsonian Disorders 60
Clinical and pathophysiological clues of respiratory dysfunction in late-onset Pompe disease: New insights from a comparative study by MRI and respiratory function assessment 60
A Systematic Review and Meta-Analysis of the Association between the FV H1299R Variant and the Risk of Recurrent Pregnancy Loss 59
Preoperative-Induced Mild Hypothermia Attenuates Neuronal Damage in a Rat Subdural Hematoma Model 58
Imaging as a biomarker in drug discovery for Alzheimer's disease: Is MRI a suitable technology? 58
CSF protein biomarker panel for assessment of neurotoxicity. 57
Neuronal and glial markers are differently associated with computed tomography findings and outcome in patients with severe traumatic brain injury: a case control study. 56
Quantitative cerebrospinal fluid biokinetic parameters of alpha II-spectrin breakdown products in severe traumatic brain injury patients 56
Genotoxic effects of anesthetic agents: an update. 56
Neuroproteomics and microRNAs studies in multiple sclerosis: transforming research and clinical knowledge in biomarker research 56
Biomarkers 56
Microvascular imaging ultrasound (MicroV) and power Doppler vascularization analysis in a pediatric population with early scrotal pain onset 56
Family, lifestyles and new and old type of smoking in young adults: insights from an italian multiple-center study 55
Translating biomarkers research to clinical care: applications and issues for rehabilomics. 54
PREDICTING POOR 6-MONTH OUTCOME IN SEVERE TBI USING THE IMPACT SCORE AND EARLY CSF BIOMARKERS. 54
Systems Biology, Bioinformatics, and Biomarkers in Neuropsychiatry 54
Effects of short-to-long term enzyme replacement therapy (ERT) on skeletal muscle tissue in late onset Pompe disease (LOPD) 53
UCH-L1 levels in CSF and Serum: Diagnosis and Outcome in Severe Traumatic Brain Injury Patients 52
Changes in Brain Biomarkers and Brain Tissue Oxygenation Following Severe Head Injury: A Case Series 52
Development of A TBI Diagnostic Assay System For Multiple Levels Of Care 51
Synthesis of Findings, Current Investigations, and Future Directions: Operation Brain Trauma Therapy 51
ECR 2018 - BOOK OF ABSTRACTS 51
Cyclosporine Treatment in Traumatic Brain Injury: Operation Brain Trauma Therapy 50
An updated overview of animal models in neuropsychiatry 49
Protective effect of apocynin, a NADPH-oxidase inhibitor, against contrast-induced nephropathy in the diabetic rats: a comparison with n-acetylcysteine. 49
Biofluid proteomics and biomarkers in traumatic brain injury 49
Brain Biomarkers and Brain Tissue Oxygenation: Changes and Correlations Following Severe Head Injury 48
Mesenchymal stem cells in the treatment of traumatic brain injury 48
CLINICAL UTILITY OF SERUM LEVELS OF UBIQUITIN C-TERMINAL HYDROLASE AS A BIOMARKER FOR SEVERE TRAUMATIC BRAIN INJURY. 47
In vivo monitoring of cytokines and brain biomarker damage following severe traumatic brain injury: a microdialysis study 47
Validazione di un protocollo abbreviato-simulato in enterografia-RM nello studio del morbo di Crohn. 47
Glial neuronal ratio: a novel index for differentiating injury type in patients with severe traumatic brain injury 46
Effect of nicotinamide on behavioral, neuropathological, and biomarker outcomes after controlled cortical impact in rats: an Operation Brain Trauma Therapy Consortium Study. 46
A neuroproteomic and systems biology analysis of rat brain post intracerebral hemorrhagic stroke. 46
Levetiracetam Treatment in Traumatic Brain Injury: Operation Brain Trauma Therapy 46
Totale 9.824
Categoria #
all - tutte 59.814
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 59.814


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020307 0 0 0 0 0 0 0 0 0 133 156 18
2020/20211.208 60 18 274 45 184 51 18 160 103 172 59 64
2021/20221.208 7 89 18 60 42 15 63 61 18 119 181 535
2022/20233.060 288 191 131 233 205 295 16 160 1.406 21 81 33
2023/20241.709 63 182 55 68 84 187 15 41 6 142 486 380
2024/20255.516 796 786 338 611 251 179 220 970 1.128 237 0 0
Totale 14.549